Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Presse Medicale (Paris, France : 1983)
|
April 25, 1987
[Treatment of rheumatoid arthritis. Comparative study of the effect of immunoglobulins G eluted from the placenta and of venoglobulins]
J Sany, J Clot, B Combe, et al.
Pediatric Nephrology (Berlin, Germany)
|
April 1, 1994
Possible pathogenic role of IgE in Henoch-Schönlein purpura
J C Davin, G Pierard, C Dechenne, et al.
Revue Medicale De Liege
|
August 4, 2022
[Bilateral periostitis and arthritis: about a case of hypertrophic osteoarthropathy]
M Mina, P Jacquerie, J-B Duquenne, et al.
Clinical and Experimental Immunology
|
November 1, 1989
Reactivity of human anti-alpha-galactosyl IgG antibody with alpha(1-->3)-linked galactosyl epitopes exposed on basement membranes and on glomerular epithelial cells: an in vitro and in vivo study in the mouse
M L Vecchi, J C Davin, V Castronovo, et al.
Clinical and Experimental Immunology
|
September 16, 1998
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
E Louis, D Franchimont, A Piron, et al.
Scandinavian Journal of Gastroenterology
|
August 23, 2002
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism
E Louis, S Vermeire, P Rutgeerts, et al.
Rheumatology International
|
June 20, 2020
Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study
R Westhovens, S E Connolly, J Margaux, et al.
Rheumatology (Oxford, England)
|
February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
P Durez, F Van den Bosch, L Corluy, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2004
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
N Franchimont, V Putzeys, J Collette, et al.
Annals of the Rheumatic Diseases
|
July 4, 2006
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
F P Luyten, P Geusens, M Malaise, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Presse Medicale (Paris, France : 1983)
|
April 25, 1987
[Treatment of rheumatoid arthritis. Comparative study of the effect of immunoglobulins G eluted from the placenta and of venoglobulins]
J Sany, J Clot, B Combe, et al.
Pediatric Nephrology (Berlin, Germany)
|
April 1, 1994
Possible pathogenic role of IgE in Henoch-Schönlein purpura
J C Davin, G Pierard, C Dechenne, et al.
Revue Medicale De Liege
|
August 4, 2022
[Bilateral periostitis and arthritis: about a case of hypertrophic osteoarthropathy]
M Mina, P Jacquerie, J-B Duquenne, et al.
Clinical and Experimental Immunology
|
November 1, 1989
Reactivity of human anti-alpha-galactosyl IgG antibody with alpha(1-->3)-linked galactosyl epitopes exposed on basement membranes and on glomerular epithelial cells: an in vitro and in vivo study in the mouse
M L Vecchi, J C Davin, V Castronovo, et al.
Clinical and Experimental Immunology
|
September 16, 1998
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
E Louis, D Franchimont, A Piron, et al.
Scandinavian Journal of Gastroenterology
|
August 23, 2002
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism
E Louis, S Vermeire, P Rutgeerts, et al.
Rheumatology International
|
June 20, 2020
Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study
R Westhovens, S E Connolly, J Margaux, et al.
Rheumatology (Oxford, England)
|
February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
P Durez, F Van den Bosch, L Corluy, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2004
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
N Franchimont, V Putzeys, J Collette, et al.
Annals of the Rheumatic Diseases
|
July 4, 2006
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
F P Luyten, P Geusens, M Malaise, et al.
Page
of 7